| Pluvicto 1000 MBq/mL solution for injection/infusion EU/1/22/1703/001 |
Lutetium (177Lu) vipivotide tetraxetan |
Advanced Accelerator Applications |
— |
| PNEUMOVAX 23 solution for injection in a vial Pneumococcal Polysaccharide Vaccine PA1286/055/001 |
Pneumococcal vaccine |
Merck Sharp & Dohme Ireland (Human Health) Limited |
Not marketed |
| PNEUMOVAX 23 solution for injection in pre-filled syringe Pneumococcal Polysaccharide Vaccine PA1286/055/002 |
Pneumococcal vaccine |
Merck Sharp & Dohme Ireland (Human Health) Limited |
Marketed |
| Polivy 140 mg powder for concentrate for solution for infusion EU/1/19/1388/001 |
Polatuzumab Vedotin |
Roche Registration GmbH |
— |
| Polivy 30 mg powder for concentrate for solution for infusion EU/1/19/1388/002 |
Polatuzumab Vedotin |
Roche Registration GmbH |
— |
| Pollenna 6C tablets HOA1149/006/001 |
Allium cepa (ghp), Euphrasia officinalis (ghp), Schoenocaulon officinale (ghp) |
A. Nelson & Company Limited |
Marketed |
| Pomalidomide Accord 1 mg hard capsules EU/1/24/1831/001-006 |
Pomalidomide |
Accord Healthcare S.L.U. |
— |
| Pomalidomide Accord 2 mg hard capsules EU/1/24/1831/007-012 |
Pomalidomide |
Accord Healthcare S.L.U. |
— |
| Pomalidomide Accord 3 mg hard capsules EU/1/24/1831/013-018 |
Pomalidomide |
Accord Healthcare S.L.U. |
— |
| Pomalidomide Accord 4 mg hard capsules EU/1/24/1831/019-024 |
Pomalidomide |
Accord Healthcare S.L.U. |
— |
| Pomalidomide Krka 1 mg hard capsules EU/1/24/1832/001-002 |
Pomalidomide |
Krka, d.d., Novo mesto |
— |
| Pomalidomide Krka 2 mg hard capsules EU/1/24/1832/003-004 |
Pomalidomide |
Krka, d.d., Novo mesto |
— |
| Pomalidomide Krka 3 mg hard capsules EU/1/24/1832/005-006 |
Pomalidomide |
Krka, d.d., Novo mesto |
— |
| Pomalidomide Krka 4 mg hard capsules EU/1/24/1832/007-008 |
Pomalidomide |
Krka, d.d., Novo mesto |
— |
| Pomalidomide Teva 1 mg Capsule, hard EU/1/24/1868/001-012 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 2 mg Capsule, hard EU/1/24/1868/013-024 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 3 mg Capsule, hard EU/1/24/1868/025-036 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 4 mg Capsule, hard EU/1/24/1868/037-048 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Viatris 1 mg hard capsules EU/1/23/1785/001-004 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 2 mg hard capsules EU/1/23/1785/005-008 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 3 mg hard capsules EU/1/23/1785/009-012 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 4 mg hard capsules EU/1/23/1785/013-016 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Zentiva 1 mg hard capsules EU/1/24/1830/001-004 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 2 mg hard capsules EU/1/24/1830/005-008 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 3 mg hard capsules EU/1/24/1830/009-012 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 4 mg hard capsules EU/1/24/1830/013-016 |
Pomalidomide |
Zentiva k.s. |
— |
| Pombiliti 105 mg powder for concentrate for solution for infusion EU/1/22/1714/001-003 |
Cipaglucosidase alfa |
Amicus Therapeutics Europe Limited |
— |
| Ponlimsi 60 mg solution for injection in pre-filled syringe EU/1/25/1986/001 |
Denosumab |
TEVA GmbH |
— |
| Ponvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tablets EU/1/21/1550/001 |
Ponesimod |
Laboratoires Juvise Pharmaceuticals |
— |
| Ponvory 20 mg film-coated tablets EU/1/21/1550/002 |
Ponesimod |
Laboratoires Juvise Pharmaceuticals |
— |
| Posaconazole Accord 100 mg gastro-resistant tablets EU/1/19/1379/001-004 |
Posaconazole |
Accord Healthcare S.L.U. |
— |
| Posaconazole AHCL 40 mg/ml oral suspension EU/1/19/1380/001 |
Posaconazole |
Accord Healthcare S.L.U. |
— |
| Potactasol 1 mg powder for concentrate for solution for infusion EU/1/10/660/001 |
Topotecan hydrochloride |
Actavis Group hf |
— |
| Potactasol 4 mg powder for concentrate for solution for infusion EU/1/10/660/002 |
Topotecan hydrochloride |
Actavis Group hf |
— |
| Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion PA2059/053/001 |
Potassium chloride, Glucose monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion PA2059/052/001 |
Potassium chloride, Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion PA2059/053/002 |
Potassium chloride, Glucose monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion PA2059/052/002 |
Potassium chloride, Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 15% w/v Concentrate for Solution for Infusion PA0073/106/001 |
Potassium chloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Potassium Chloride 15% w/v Concentrate for Solution for Infusion PA2059/054/001 |
Potassium chloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| POTELIGEO 4 mg/mL concentrate for solution for infusion EU/1/18/1335/001 |
MOGAMULIZUMAB |
Kyowa Kirin Holdings B.V. |
— |
| Pradaxa 110 mg coated granules EU/1/08/442/0029 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg hard capsules EU/1/08/442/5-8 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg coated granules EU/1/08/442/030 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg hard capsules EU/1/08/442/009-013 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 20 mg coated granules EU/1/08/442/025 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 30 mg coated granules EU/1/08/442/0026 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 40 mg coated granules EU/1/08/442/0027 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 50 mg coated granules EU/1/08/442/028 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 75 mg hard capsules EU/1/08/442/1-4 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |